within Pharmacolibrary.Drugs.C_CardiovascularSystem.C09C_AngiotensinIiReceptorBlockersArbsPlain.C09CA03_Valsartan;

model Valsartan
  extends Pharmacolibrary.Drugs.ATC.C.C09CA03_1;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>Valsartan_1</td></tr><tr><td>ATC code:</td><td>C09CA03_1</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Valsartan is an angiotensin II receptor blocker (ARB) used for treating hypertension and heart failure and for protection after myocardial infarction.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic model in healthy adults after a single oral dose administration.</p><h4>References</h4><ol><li><p>Ngo, L, et al., &amp; Lee, YB (2018). Effects of hydrochlorothiazide and amlodipine on single oral dose pharmacokinetics of valsartan in healthy Korean subjects: Population model-based approach. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 118 154–164. DOI:<a href=\"https://doi.org/10.1016/j.ejps.2018.03.031\">10.1016/j.ejps.2018.03.031</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29604332/\">https://pubmed.ncbi.nlm.nih.gov/29604332</a></p></li><li><p>Sioufi, A, et al., &amp; Lloyd, P (1998). The effect of age on the pharmacokinetics of valsartan. <i>Biopharmaceutics &amp; drug disposition</i> 19(4) 237–244. DOI:<a href=\"https://doi.org/10.1002/(sici)1099-081x(199805)19:4&lt;237::aid-bdd100&gt;3.0.co;2-7\">10.1002/(sici)1099-081x(199805)19:4&lt;237::aid-bdd100&gt;3.0.co;2-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9604123/\">https://pubmed.ncbi.nlm.nih.gov/9604123</a></p></li><li><p>Iqbal, M, et al., &amp; Sharma, PL (2010). Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers. <i>Clinical therapeutics</i> 32(3) 588–596. DOI:<a href=\"https://doi.org/10.1016/j.clinthera.2010.03.004\">10.1016/j.clinthera.2010.03.004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20399995/\">https://pubmed.ncbi.nlm.nih.gov/20399995</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Valsartan;
